We are thrilled to have recently welcomed Ben Travers, TASKA’s new Chief Executive Officer. Ben Travers brings with him a wealth of invaluable experience in the field of medical technology, cultivated through a distinguished career that spans both local and international arenas.

Over a remarkable 17-year tenure at Johnson & Johnson (J&J), Ben held various pivotal roles, including Vice President for the Australian orthopaedics business, General Manager and Country Director for the company in New Zealand, and Senior Global Director, where he led the commercial relationship with a top-tier international healthcare provider.

Ben's alignment with our mission to restore mobility and confidence is nothing short of exceptional. His extensive background in advancing movement strongly resonates with our organisational goals. With his appointment, we usher in an exhilarating new era as we unveil an ambitious 3–5-year plan. This comprehensive strategy is meticulously designed to elevate user experiences on a global scale and redefine the relationship between technology and limb loss/limb difference.

With Ben's strategic guidance and our partners’ collaborative efforts, we stand poised to achieve remarkable milestones that will not only reshape but also revolutionise the landscape of medical technology. Together, we embark on an exciting journey towards a brighter future for people with upper limb differences.